glp-1 and gip receptor agonist The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Mechanisms of action of GLP-1

According to the Diabetes UK , an estimated 6.3 million people are at an increased risk of type 2 diabetes in the UK based on blood sugar levels

I have diarrhoea and vomiting with my GLP-1 agonist, and I take the contraceptive pill, what should I do

Diamant M, Van Gaal L, Guerci B, et al

They, therefore, have favourable effect on glucose metabolism and lead to significant caloric intake reduction and resultant weight reduction, usually in the vicinity of 3 - 8 kg depending on the dose and agent used

However, emerging lawsuits claim the drug caused an eye condition called non-arteritic anterior ischemic optic neuropathy NAION

Consequently, a better ability to intensify treatment upon failure, presumably because of tighter control, may add to the long-term efficacy of GLP-1RA and improved outcomes for patients